TLR9 and Allergy: Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotide, as an agonist of Toll-like receptor 9 (TLR9), activates immune responses for use as vaccines to treat cancer, infectious diseases, and allergies (Bai et al., 2017).